Wang Han, Ma Jianrui, Han Linjiang, Tan Tong, Xie Wen, Tian Miao, Tujia Zichao, Li Ying, Liu Xiang, Liu Xiaobing, Yuan Haiyun, Chen Jimei
Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080 Guangzhou, Guangdong, China.
Guangdong Provincial Key Laboratory of South China Structural Heart Disease, 510080 Guangzhou, Guangdong, China.
Rev Cardiovasc Med. 2024 May 27;25(6):193. doi: 10.31083/j.rcm2506193. eCollection 2024 Jun.
The impact of dominant ventricular morphology on Fontan patient outcomes remain controversial. This study evaluates long-term results of right ventricle (RV) dominance versus left ventricle (LV) dominance in Fontan circulation without hypoplastic left heart syndrome (HLHS).
We retrospectively examined 323 Fontan operations from our center. To minimize pre- and intra-Fontan heterogeneity, 42 dominant RV patients were matched with 42 dominant LV patients using propensity score matching, allowing for a comparative analysis of outcomes between groups.
The mean follow-up was 8.0 4.6 years for matched RV dominant and 6.5 4.7 years for matched LV dominant group ( 0.05), showing no significant difference. The cumulative incidence of moderate or greater atrioventricular valve regurgitation was also comparable between the two groups ( 0.05). Similarly, 10-year freedom from death or transplantation following the Fontan operation was 84% 7% in the matched dominant RV group, similar to 81% 7% in the matched dominant LV group ( 0.05). The 10-year freedom from Fontan failure was 78% 8% in the matched dominant RV group, also similar to 75% 8% in the matched dominant LV group ( 0.05). Multivariate analysis did not identify RV dominance as a risk factor for Fontan failure ( 0.05).
In the pre- and intra-Fontan context, RV dominance demonstrated similar and comparable long-term outcomes compared to LV dominance in non-HLHS Fontan circulation.
优势心室形态对Fontan手术患者预后的影响仍存在争议。本研究评估了在无左心发育不全综合征(HLHS)的Fontan循环中,右心室(RV)优势与左心室(LV)优势的长期结果。
我们回顾性研究了本中心的323例Fontan手术。为尽量减少Fontan手术前和手术中的异质性,采用倾向得分匹配法将42例右心室优势患者与42例左心室优势患者进行匹配,以便对两组间的预后进行比较分析。
匹配的右心室优势组平均随访时间为8.0±4.6年,匹配的左心室优势组为6.5±4.7年(P>0.05),无显著差异。两组中度或更严重的房室瓣反流累积发生率也相当(P>0.05)。同样,Fontan手术后10年无死亡或移植的生存率在匹配的右心室优势组为84%±7%,与匹配的左心室优势组的81%±7%相似(P>0.05)。匹配的右心室优势组Fontan手术失败10年的无失败生存率为78%±8%,也与匹配的左心室优势组的75%±8%相似(P>0.05)。多因素分析未将右心室优势确定为Fontan手术失败的危险因素(P>0.05)。
在Fontan手术前和手术过程中,在非HLHS的Fontan循环中,右心室优势与左心室优势相比,显示出相似且可比的长期预后。